NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Imaging Systems
- Sub-Industry: N/A
- Symbol: NASDAQ:NVDQ
- CUSIP: N/A
- Web: novadaq.com
- Market Cap: $679.41 million
- Outstanding Shares: 57,822,000
- 50 Day Moving Avg: $11.68
- 200 Day Moving Avg: $9.03
- 52 Week Range: $5.84 - $12.74
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -16.32
- P/E Growth: 0.00
- Annual Revenue: $83.87 million
- Price / Sales: 8.10
- Book Value: $1.54 per share
- Price / Book: 7.63
- EBIDTA: ($50,470,000.00)
- Net Margins: -66.61%
- Return on Equity: -51.89%
- Return on Assets: -40.92%
- Debt-to-Equity Ratio: 0.11%
- Current Ratio: 3.49%
- Quick Ratio: 3.30%
- Average Volume: 1.41 million shs.
- Beta: 0.71
- Short Ratio: 0.72
Frequently Asked Questions for Novadaq Technologies (NASDAQ:NVDQ)
What is Novadaq Technologies' stock symbol?
Novadaq Technologies trades on the NASDAQ under the ticker symbol "NVDQ."
How were Novadaq Technologies' earnings last quarter?
Novadaq Technologies Inc. (NASDAQ:NVDQ) issued its earnings results on Wednesday, May, 3rd. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.03. The business earned $21.08 million during the quarter, compared to the consensus estimate of $20.12 million. Novadaq Technologies had a negative net margin of 66.61% and a negative return on equity of 51.89%. View Novadaq Technologies' Earnings History.
When will Novadaq Technologies make its next earnings announcement?
Where is Novadaq Technologies' stock going? Where will Novadaq Technologies' stock price be in 2017?
13 brokerages have issued twelve-month price targets for Novadaq Technologies' stock. Their predictions range from $11.00 to $13.25. On average, they expect Novadaq Technologies' share price to reach $11.86 in the next year. View Analyst Ratings for Novadaq Technologies.
What are analysts saying about Novadaq Technologies stock?
Here are some recent quotes from research analysts about Novadaq Technologies stock:
- 1. According to Zacks Investment Research, "Novadaq Technologies Inc. develops, manufactures and markets real-time fluorescence imaging products for use in the operating room and other clinical settings. The company's key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. It provides SPY imaging systems which enables surgeons to the visualize blood flow in vessels, co-joined vessels and micro-vessels. Novadaq Technologies Inc. is headquartered in Mississauga, Canada. " (8/18/2017)
- 2. Northland Securities analysts commented, "We feel somewhat vindicated that the core biz was not doing OK, forward estimates were out of whack, and the bullish sell-side commentary at large was not based on a true understanding of the science…or ground fundamentals…Yes, it is water under the bridge now…..but sometimes postmortems are necessary." (8/14/2017)
- 3. Stifel Nicolaus analysts commented, "We continue to believe the underlying value proposition of the larger NVDQ story remains unchanged. The combination of our high level of conviction in the company's highly differentiated and clinically relevant technology, a very solid balance sheet (at least 3-4 years of cash with revolver) with no need for near-term dilutive financing, and the shares' discounted valuation are enough, in our view, to continue recommending the shares... . In the long run, if these initiatives are even remotely successful, we believe it argues for a much higher value for the company, standalone or for potential strategic acquirers. On the basis of our new, now lower 2017 projections, adjusted down largely to reflect the impact of a new flexible capital acquisition model, we lower our TP to $10 (from $16)." (3/1/2017)
Who are some of Novadaq Technologies' key competitors?
Some companies that are related to Novadaq Technologies include Genus plc (GNS), TherapeuticsMD (TXMD), TherapeuticsMD (TXMD), Clinigen Group PLC (CLIN), Knight Therapeutics (GUD), Knight Therapeutics (GUD), Asante Solutions (PUMP), ProMetic Life Sciences (PLI), National HealthCare (NHC), Spire Healthcare Group PLC (SPI), Albany Molecular Research (AMRI), Canfor Pulp Products (CFX), Novadaq Technologies (NDQ), CVS Group Plc (CVSG), Extendicare (EXE), Myovant Sciences Ltd (MYOV), Ignyta (RXDX) and Vectura Group PLC (VEC).
Who are Novadaq Technologies' key executives?
Novadaq Technologies' management team includes the folowing people:
- William A. MacKinnon, Chairman of the Board
- Rick Mangat Ph.D., President, Chief Executive Officer
- Roger Deck, Chief Financial Officer
- Lori Swalm, Vice President of Marketing
- Derrick Guo, General Counsel, Corporate Secretary
- Anthony F. Griffiths, Lead Independent Director
- Lisa N. Colleran, Director
- Karen A. Licitra, Director
- Patrice E. Merrin, Independent Director
- Thomas G. Wellner, Independent Director
Who owns Novadaq Technologies stock?
Novadaq Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (9.18%), Riverbridge Partners LLC (5.47%), Janus Henderson Group PLC (4.82%), Sand Grove Capital Management LLP (3.99%), Goldman Sachs Group Inc. (3.14%) and Elk Creek Partners LLC (2.61%). View Institutional Ownership Trends for Novadaq Technologies.
Who sold Novadaq Technologies stock? Who is selling Novadaq Technologies stock?
Novadaq Technologies' stock was sold by a variety of institutional investors in the last quarter, including Elk Creek Partners LLC, Jennison Associates LLC, Granite Investment Partners LLC, Blair William & Co. IL, Riverbridge Partners LLC, CWM LLC, Bank of New York Mellon Corp and Garrison Bradford & Associates Inc.. View Insider Buying and Selling for Novadaq Technologies.
Who bought Novadaq Technologies stock? Who is buying Novadaq Technologies stock?
Novadaq Technologies' stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Sand Grove Capital Management LLP, Goldman Sachs Group Inc., Broadfin Capital LLC, CNH Partners LLC, Commonwealth of Pennsylvania Public School Empls Retrmt SYS, OMERS ADMINISTRATION Corp and Longfellow Investment Management Co. LLC. View Insider Buying and Selling for Novadaq Technologies.
How do I buy Novadaq Technologies stock?
Shares of Novadaq Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Novadaq Technologies' stock price today?
MarketBeat Community Rating for Novadaq Technologies (NASDAQ NVDQ)MarketBeat's community ratings are surveys of what our community members think about Novadaq Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Novadaq Technologies stock can currently be purchased for approximately $11.75.
Consensus Ratings for Novadaq Technologies (NASDAQ:NVDQ) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||11 Hold Ratings, 2 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.15)|
|Consensus Price Target: ||$11.86 (0.91% upside)|
Analysts' Ratings History for Novadaq Technologies (NASDAQ:NVDQ)
(Data available from 9/26/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/1/2017||Royal Bank Of Canada||Reiterated Rating||Hold||$11.75||N/A|
|9/1/2017||Canaccord Genuity||Reiterated Rating||Hold||$11.75||Low|
|8/14/2017||Northland Securities||Reiterated Rating||Hold||$11.75||Medium|
|7/13/2017||JMP Securities||Reiterated Rating||Outperform -> Market Perform||Low|
|6/20/2017||First Analysis||Downgrade||Overweight -> Equal Weight||Low|
|6/20/2017||Scotiabank||Lower Price Target||Outperform||$15.50 -> $13.25||Low|
|6/20/2017||Stifel Nicolaus||Downgrade||Buy -> Hold||$11.75||Low|
|6/19/2017||Craig Hallum||Downgrade||Buy -> Hold||$11.75||Low|
|6/19/2017||Wedbush||Downgrade||Outperform -> Neutral||N/A|
|3/1/2017||Feltl & Co.||Downgrade||Buy -> Hold||N/A|
|1/11/2017||William Blair||Downgrade||Outperform -> Market Perform||N/A|
|11/16/2016||BTIG Research||Reiterated Rating||Hold||N/A|
|11/3/2016||Noble Financial||Downgrade||Strong-Buy -> Buy||N/A|
|3/11/2016||Piper Jaffray Companies||Reiterated Rating||Buy||N/A|
Earnings History for Novadaq Technologies (NASDAQ:NVDQ)Earnings History by Quarter for Novadaq Technologies (NASDAQ NVDQ)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/1/2017|| || || || || || || || |
|5/3/2017||Q1||($0.21)||($0.24)||$20.12 million||$21.08 million||View||Listen|
|2/28/2017||12/31/2016||($0.17)||($0.32)||$21.08 million||$20.10 million||View||Listen|
|11/2/2016||Q3 2016||($0.16)||($0.19)||$22.21 million||$22.16 million||View||N/A|
|7/27/2016||Q216||($0.14)||($0.29)||$19.97 million||$20.12 million||View||Listen|
|4/27/2016||Q116||($0.17)||($0.14)||$17.49 million||$17.70 million||View||Listen|
|2/17/2016||Q415||($0.15)||($0.17)||$19.02 million||$20.00 million||View||Listen|
|10/28/2015||Q315||($0.20)||($0.11)||$16.32 million||$17.04 million||View||Listen|
|7/28/2015||Q215||($0.17)||($0.22)||$13.99 million||$15.07 million||View||Listen|
|4/28/2015||Q115||($0.09)||($0.20)||$13.10 million||$11.70 million||View||N/A|
|2/25/2015||Q4 2014||($0.09)||($0.10)||$13.00 million||$13.02 million||View||N/A|
|11/6/2014||Q414||($0.07)||($0.17)||$12.10 million||$12.10 million||View||N/A|
|8/5/2014||Q2||($0.07)||($0.08)||$11.33 million||$11.20 million||View||N/A|
|5/7/2014||Q114||($0.05)||($0.08)||$10.33 million||$10.30 million||View||N/A|
|2/6/2014||Q4||($0.03)||($0.06)||$10.37 million||$10.70 million||View||N/A|
|10/22/2013||Q313||($0.03)||($0.14)||$8.68 million||$8.90 million||View||N/A|
|8/1/2013||Q213||($0.02)||($0.05)||$7.89 million||$8.10 million||View||N/A|
|4/29/2013||Q113||($0.04)||($0.02)||$6.94 million||$7.30 million||View||N/A|
|2/7/2013||Q412||($0.05)||($0.01)||$6.43 million||$6.80 million||View||N/A|
|11/2/2012||Q312||($0.05)||($0.03)||$5.75 million||$5.10 million||View||N/A|
Earnings Estimates for Novadaq Technologies (NASDAQ:NVDQ)
2017 EPS Consensus Estimate: ($0.72)
2018 EPS Consensus Estimate: ($0.90)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Novadaq Technologies (NASDAQ:NVDQ)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Novadaq Technologies (NASDAQ:NVDQ)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Novadaq Technologies (NASDAQ:NVDQ)
Latest Headlines for Novadaq Technologies (NASDAQ:NVDQ)
Novadaq Technologies (NVDQ) Chart for Tuesday, September, 26, 2017